- Entry
- $5.28
- Final
- $4.37 -17.2%
- Target
- —
- Score
- -1.00
About $80k worth of RXRX. Stock is sold 39% short because old school Wall Street doesn’t think Ai is “real science”. The company has a “digital cell” methodology where they can try millions of combinations of how various compounds affect a human cell, via Ai. Jensen Huang invested and so should you. Chart is DEFINITELY showing signs of accumulation.
— ORIGINAL POST ·
12800 Shares of RXRX
· r/wallstreetbets
· Oct 8, 2025